An Open‐Label, Single‐Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non‐Small Cell Lung Cancer After First‐Line PD ‐(L)1 Inhibitor

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Xun Shi, Chen Lin, Lishu Lou, Qiong He, Guangyuan Lou, Wei Hong, Lan Shao, Jun Zhao, Cuiping Gu, Xinmin Yu, Ying Jin
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Cancer Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet